Flow Cytometry Market Seeking Growth from Emerging Study Drivers, Restraints and Forecast 2025 Appraised By Global Players Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, I

Flow cytometry is a laser- or impedance-based, biophysical technology employed in cell counting, cell sorting, biomarker detection and protein engineering. The process is conducted by suspending cells in a stream of fluid and passing them through an electronic detection apparatus. The simultaneous multiparametric analysis of the physical and chemical characteristics of particles is facilitated by a flow cytometer at a speed of up to thousands of particles per second. The process is used in the diagnosis of health disorders such as blood cancers along with several applications in basic research, clinical practice, and clinical trials.

Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1152

Flow cytometry facilitates study of the expression of cell surface and intracellular molecules along with characterization of different cell types in a heterogeneous cell population. Moreover, flow cytometry also allows simultaneous multi-parameter analysis of single cells. The combination of technological improvements, growing research activities in life science and increasing clinical application of flow cytometry in diagnosis of HIV and cancer are some of the major factors driving growth of the flow cytometry market.

Increase In Clinical Applications Of Flow Cytometry Is Expected To Favor The Flow Cytometry Market

The use of flow cytometry in clinical laboratory has grown substantially due to the development of smaller, user-friendly, less expensive instruments and increasing number of research application such as, immunophenotyping, cell sorting, cell cycle analysis, Apoptosis, cell proliferation assays, and intracellular calcium flux is expected to favor the growth of flow cytometry market. Besides, flow cytometry has a unique ability to investigate large cell populations at the single-cell level. This favors the adoption of flow cytometry for clinical application.

Furthermore, flow cytometry is also gaining attraction in drug discovery and development, which helps transforming every stage of preclinical and clinical development, that guide new product evaluation, selection and monitoring. Flow cytometry increases the probability of success in drug development and also allows for more informed decision making. The demand for flow cytometry is growing at all phases of development from early to late favoring the growth of flow cytometry use in industry for drug development process.

Flow cytometry is also employed in testing of CD4 count in order to treat HIV patients with suitable antiretroviral drugs. The BD Biosciences provides CD4 testing facilities and products. BD Biosciences has 3 different systems, namely, BD FACSCount system, mostly used in emerging economies, owing to its ease of use; the BD FACSCalibur system is used in large-volume labs where over 1,000,000 tests are performed annually, and the BD FACSCanto II system, used for HIV monitoring and other applications.
Some major players operating in the flow cytometry market are Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc. and Danaher Corporation.

Inquire Here Before Purchase of Research Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/1152

Detailed Segmentation:

• Global Flow Cytometry Market, By Technology:
◦ Cell Based
◦ Bead Based

• Global Flow Cytometry Market, By Product:
◦ Analyzer
◦ Sorter
◦ Reagents & Consumables

• Global Flow Cytometry Market, By End User:
◦ Hospitals
◦ Clinical Testing Labs
◦ Research Laboratories

• Global Flow Cytometry Market, By Geography:
◦ North America
◦ Europe
◦ Asia Pacific
◦ Latin America
◦ Middle East
◦ Africa

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.